MedPath
HSA Approval

NAABAK EYEDROPS 4.9%

SIN11294P

NAABAK EYEDROPS 4.9%

NAABAK EYEDROPS 4.9%

March 21, 2000

DCH AURIGA SINGAPORE

DCH AURIGA SINGAPORE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION

OPHTHALMIC

Medical Information

S01GX03

spaglumic acid

Manufacturer Information

DCH AURIGA SINGAPORE

LABORATOIRES THISSEN SA

EXCELVISION

Active Ingredients

N-ACETYL ASPARTYL GLUTAMIC ACID SODIUM SALT

4.9%

n-acetyl aspartyl glutamic acid sodium salt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.